Trial
NCT04003896
A Study to Evaluate Abemaciclib in Advanced Biliary Tract Carcinoma
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Milton S. Hershey Medical Center
Collaborators
Eli Lilly and Company
Condition
Biliary Tract Carcinoma
Intervention
Abemaciclib
Why stopped
The manufacturer and funder Eli Lilly requested to terminate the study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-10-08